These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3655023)
1. Use of cyclophosphamide in azathioprine failures in pemphigus. Ahmed AR; Hombal S J Am Acad Dermatol; 1987 Sep; 17(3):437-42. PubMed ID: 3655023 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris. Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113 [TBL] [Abstract][Full Text] [Related]
3. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases. Mahajan VK; Sharma NL; Sharma RC; Garg G Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182 [TBL] [Abstract][Full Text] [Related]
4. Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris. Fellner MJ; Katz JM; McCabe JB Arch Dermatol; 1978 Jun; 114(6):889-94. PubMed ID: 666324 [TBL] [Abstract][Full Text] [Related]
5. Steroid-pulse therapy in pemphigus vulgaris long term follow-up. Chryssomallis F; Dimitriades A; Chaidemenos GC; Panagiotides D; Karakatsanis G Int J Dermatol; 1995 Jun; 34(6):438-42. PubMed ID: 7657447 [TBL] [Abstract][Full Text] [Related]
6. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide]. España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. Baum S; Debby A; Gilboa S; Trau H; Barzilai A Dermatology; 2016; 232(5):578-585. PubMed ID: 27698327 [TBL] [Abstract][Full Text] [Related]
8. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients. Kim MR; Kim HC; Kim SC Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975. Lever WF; Schaumburg-Lever G Arch Dermatol; 1977 Sep; 113(9):1236-41. PubMed ID: 900969 [TBL] [Abstract][Full Text] [Related]
10. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. Rose E; Wever S; Zilliken D; Linse R; Haustein UF; Bröcker EB J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814 [TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy. Citarrella P; Gebbia V; Di Marco P; Tambone Reyes M; Noto G; Aricò M J Chemother; 1992 Feb; 4(1):56-8. PubMed ID: 1403072 [TBL] [Abstract][Full Text] [Related]
12. [Therapy of pemphigus. Critical remarks based on 44 clinical cases]. Smolle J Hautarzt; 1985 Feb; 36(2):96-102. PubMed ID: 2985524 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy of bullous pemphigoid with dapsone. Jeffes EW; Ahmed AR Clin Exp Dermatol; 1989 Mar; 14(2):132-6. PubMed ID: 2689016 [TBL] [Abstract][Full Text] [Related]
14. Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy. Lamey PJ; Rees TD; Binnie WH; Wright JM; Rankin KV; Simpson NB Oral Surg Oral Med Oral Pathol; 1992 Jul; 74(1):54-7. PubMed ID: 1508510 [TBL] [Abstract][Full Text] [Related]
15. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study. Chaidemenos G; Apalla Z; Koussidou T; Papagarifallou I; Ioannides D J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):206-10. PubMed ID: 20569289 [TBL] [Abstract][Full Text] [Related]
16. Juvenile pemphigus. Ahmed AR; Salm M J Am Acad Dermatol; 1983 Jun; 8(6):799-807. PubMed ID: 6306073 [TBL] [Abstract][Full Text] [Related]
17. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373 [TBL] [Abstract][Full Text] [Related]
18. Network meta-analysis-based comparison of first-line steroid-sparing adjuvants in the treatment of pemphigus vulgaris and pemphigus foliaceus. Lee MS; Yeh YC; Tu YK; Chan TC J Am Acad Dermatol; 2021 Jul; 85(1):176-186. PubMed ID: 32798583 [TBL] [Abstract][Full Text] [Related]